XBIOXenetic Biosciences, Inc.vs its industry peers
A metric-by-metric comparison of Xenetic Biosciences, Inc. against SIC 2834 — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| 기업 | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| XBIO본 종목 | $5M#5 | — | 0.9x#3 | 1.7x#3 | 19.0%#2 | 32.3%#4 | -95.2%#2 | -44.1%#2 | -1516.8%#3 | 4#1 | -35.3%#2 | — |
| BOLT | $7M#1 | — | 0.6x#1 | 0.9x#2 | 0.1%#3 | 47.1%#3 | -469.3%#3 | -264.1%#3 | — | — | -28.8%#1 | — |
| ENVB | $7M#2 | — | 0.8x#2 | 0.2x#1 | -7.2%#4 | 26.0%#5 | -22.0%#1 | 149.7%#1 | -100.4%#1 | 3#2 | — | — |
| ERNA | $6M#3 | 0.1x#1 | 2.0x#4 | 11.0x#4 | 755.9%#1 | 68.4%#2 | -1601.2%#4 | -440.1%#4 | -1016.2%#2 | — | -87.4%#4 | — |
| PCSA | $5M#4 | 2.9x#2 | — | — | — | 214.5%#1 | — | — | — | — | -62.5%#3 | 0.8%#1 |
Peer set: US filers sharing this company's SEC industry classification (SIC 2834). SIC is coarse — conglomerates and multi-segment companies map imperfectly. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Some peers are still being computed, so this table covers part of the group and ranks are within the rows shown; it fills in shortly. 이 표는 생성 중 시간이 초과되어 그룹의 일부만 포함합니다. 순위는 표시된 행 내에서만 유효하며 곧 채워집니다. Table built 2026-09-16.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice